# SUCCINYLCHOLINE CHLORIDE
> **ANDA211346** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2020-11-20
## Drug
- **FDA Application Number:** ANDA211346
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCCINYLCHOLINE CHLORIDE
- **Generic name:** SUCCINYLCHOLINE CHLORIDE
- **Active ingredients:** SUCCINYLCHOLINE CHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2020-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211346)
---
*AI Analytics · CC0 1.0*